PATEL DINESH V PH D
President and CEO
DirectorOfficer
Latest Insider Transactions
Showing 10 of 26 transactions (past 365 days)
| 2026-05-15 | 2026-05-12 | PTGX Protagonist Therapeutics, Inc | CEO | Exercise Conversion | 75,000 | $21.58 | $1,618,500 |
| 2026-05-15 | 2026-05-12 | PTGX Protagonist Therapeutics, Inc | CEO | Sale | 75,000 | $100.12 | $7,509,000 |
| 2026-05-15 | 2026-05-12 | PTGX Protagonist Therapeutics, Inc | CEO | Exercise Conversion | 75,000 | $21.58 | $1,618,500 |
| 2026-05-12 | 2026-05-12 | PTGX Protagonist Therapeutics, Inc | CEO | Exercise Conversion | 75,000 | $21.58 | $1,618,500 |
| 2026-05-12 | 2026-05-12 | PTGX Protagonist Therapeutics, Inc | CEO | Sale | 75,000 | $100.12 | $7,509,000 |
| 2026-05-12 | 2026-05-12 | PTGX Protagonist Therapeutics, Inc | CEO | Exercise Conversion | 75,000 | $21.58 | $1,618,500 |
| 2026-04-24 | 2026-04-23 | PTGX Protagonist Therapeutics, Inc | CEO | Gift | 1,460 | $0.00 | $0 |
| 2026-03-25 | 2026-03-25 | PTGX Protagonist Therapeutics, Inc | CEO | Exercise Conversion | 54,641 | $0.00 | $0 |
| 2026-03-25 | 2026-03-25 | PTGX Protagonist Therapeutics, Inc | CEO | Sale | 54,641 | $101.00 | $5,518,741 |
| 2026-03-25 | 2026-03-25 | PTGX Protagonist Therapeutics, Inc | CEO | Exercise Conversion | 54,641 | $8.58 | $468,820 |
PTGX
CEO
Exercise Conversion
$1.6M
75,000 shares @ $21.58
Filed 2026-05-15Trade 2026-05-12
Protagonist Therapeutics, IncPTGX
CEO
Sale
$7.5M
75,000 shares @ $100.12
Filed 2026-05-15Trade 2026-05-12
Protagonist Therapeutics, IncPTGX
CEO
Exercise Conversion
$1.6M
75,000 shares @ $21.58
Filed 2026-05-15Trade 2026-05-12
Protagonist Therapeutics, IncPTGX
CEO
Exercise Conversion
$1.6M
75,000 shares @ $21.58
Filed 2026-05-12Trade 2026-05-12
Protagonist Therapeutics, IncPTGX
CEO
Sale
$7.5M
75,000 shares @ $100.12
Filed 2026-05-12Trade 2026-05-12
Protagonist Therapeutics, IncPTGX
CEO
Exercise Conversion
$1.6M
75,000 shares @ $21.58
Filed 2026-05-12Trade 2026-05-12
Protagonist Therapeutics, IncPTGX
CEO
Exercise Conversion
$0
54,641 shares @ $0.00
Filed 2026-03-25Trade 2026-03-25
Protagonist Therapeutics, IncPTGX
CEO
Sale
$5.5M
54,641 shares @ $101.00
Filed 2026-03-25Trade 2026-03-25
Protagonist Therapeutics, IncPTGX
CEO
Exercise Conversion
$468.8K
54,641 shares @ $8.58
Filed 2026-03-25Trade 2026-03-25
Protagonist Therapeutics, IncWant to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.